Mubadala Capital
We invest in later-stage healthcare and therapeutics companies at Series C or later, and mid-cap private equity investments in the therapeutics and healthcare space. Healthcare private equity investments in AI for healthcare optimization, pharmaceutical infrastructure, supply chain, pharmaceutical services, clinical trial optimization, pharmaceutical manufacturing, healthcare logistics, diagnostics, and medical devices. Healthcare and health-tech companies should have at least $10mn in revenue. Therapeutics companies with at least Phase 2 data looking for an investment to help scale Phase 3 trials and commercialization, including precision oncology, neuroscience, auto-immune, AI/ML-enabled discovery, RNA-targeting, gene therapy, peptides, and other breakthrough areas.
Address
San FranciscoCalifornia
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}